You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Bisoprolol fumarate - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for bisoprolol fumarate and what is the scope of freedom to operate?

Bisoprolol fumarate is the generic ingredient in four branded drugs marketed by Alembic, Aurobindo Pharma, Dash Pharms Natco, Harman Finochem, Novitium Pharma, Prinston Inc, Rubicon, Teva Pharms, Unichem, United Res Labs, Zydus Lifesciences, Teva Womens, Actavis Elizabeth, Apothecon, Cadila, Chartwell Rx, Edenbridge Pharms, Epic Pharma Llc, Glenmark Pharms Ltd, Ivax Sub Teva Pharms, Mylan, Teva, Watson Labs Teva, and Teva Branded Pharm, and is included in twenty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for bisoprolol fumarate. Nineteen suppliers are listed for this compound.

Summary for bisoprolol fumarate

US Patents:	0
Tradenames:	4
Applicants:	24
NDAs:	26
Drug Master File Entries:	11
Finished Product Suppliers / Packagers:	19
Raw Ingredient (Bulk) Api Vendors:	212
Clinical Trials:	8
Patent Applications:	5,216
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for bisoprolol fumarate
What excipients (inactive ingredients) are in bisoprolol fumarate?	bisoprolol fumarate excipients list
DailyMed Link:	bisoprolol fumarate at DailyMed

See drug prices for bisoprolol fumarate

Recent Clinical Trials for bisoprolol fumarate

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Damanhour University	Phase 2
Alexandria University	Phase 2
Université de Sherbrooke	N/A

See all bisoprolol fumarate clinical trials

Pharmacology for bisoprolol fumarate

Drug Class	beta-Adrenergic Blocker
Mechanism of Action	Adrenergic beta-Antagonists

Medical Subject Heading (MeSH) Categories for bisoprolol fumarate

Adrenergic beta-1 Receptor Antagonists
Antihypertensive Agents
Sympatholytics

US Patents and Regulatory Information for bisoprolol fumarate

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Glenmark Pharms Ltd	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	bisoprolol fumarate; hydrochlorothiazide	TABLET;ORAL	215995-003	Jan 26, 2022	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Zydus Lifesciences	BISOPROLOL FUMARATE	bisoprolol fumarate	TABLET;ORAL	215680-002	Jul 25, 2022	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Unichem	BISOPROLOL FUMARATE	bisoprolol fumarate	TABLET;ORAL	078635-002	Aug 18, 2009	AB	RX	No	Yes	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Rubicon	BISOPROLOL FUMARATE	bisoprolol fumarate	TABLET;ORAL	075643-001	Nov 16, 2000	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Teva	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	bisoprolol fumarate; hydrochlorothiazide	TABLET;ORAL	075686-001	Jan 19, 2001		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for bisoprolol fumarate

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Teva Womens	ZEBETA	bisoprolol fumarate	TABLET;ORAL	019982-002	Jul 31, 1992	⤷ Try a Trial	⤷ Try a Trial
Teva Womens	ZEBETA	bisoprolol fumarate	TABLET;ORAL	019982-001	Jul 31, 1992	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.